Hepatitis C drugs Market Overview, Business Opportunities, Sales and Revenue, Supply Chain, Challenges by 2030
Overview:
Hepatitis C drugs market was valued USD 18700 million and expected to reach USD 281.55 million by the end of forecasting period reflecting a sluggish CAGR of 1.17% by 2030.
The hepatitis C drug market is getting bolstered by the increasing disease prevalence, effective use of government subsidy and reimbursement schemes, increasing screening opportunities, drug abuse in several...
0 Reacties
0 aandelen
1323 Views